| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.7M | -22.8% |
| R&D Expense | $175.0M | +22.8% |
| SG&A Expense | $70.7M | -7.2% |
| Operating Income | -$225.9M | -17.0% |
| Income Tax | $0 | — |
| Net Income | -$220.4M | -14.5% |
| EPS (Basic) | -$3.21 | -12.6% |
| EPS (Diluted) | -$3.21 | -13.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $141.5M | -30.5% |
| Short-term Investments | $202.8M | -31.6% |
| Accounts Receivable | $5.1M | +1827.0% |
| Current Assets | $356.8M | -29.7% |
| Total Assets | $514.3M | -24.1% |
| Current Liabilities | $60.1M | +28.2% |
| Total Liabilities | $153.6M | +24.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$177.3M | -8.3% |
| Capital Expenditures | $4.1M | -48.4% |
| Investing Cash Flow | $114.1M | +309.4% |
| Financing Cash Flow | $1.3M | -99.5% |
| Free Cash Flow | -$181.5M | -5.6% |
| Stockholders' Equity |
| $360.7M |
| -34.9% |